Buy & Sell BioNano Genomics Inc (BNGO) – BioNano Genomics Inc Price Today
Aura AI Summary
Key Stats
- $14.46MMarket Cap
- HealthSector
- -22.6%3M Drawdown
- $17.07MEnterprise Value
- -Dividend Yield
- 94% Buy | 6% SellTrading Activity
- 43 daysTypical Hold Time
BioNano Genomics Inc (BNGO) is currently valued at a market capitalization of $14.46M, with an enterprise value of $17.07M. Over the past 52 weeks, BioNano Genomics Inc has traded between a low of $1.09 and a high of $4.92, highlighting its annual price range. Over the past three months, BioNano Genomics Inc has recorded a drawdown of -22.6%, reflecting recent price volatility. On average, investors hold BioNano Genomics Inc for approximately 43 days, indicating typical investor behavior on the platform.
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Most Recent News
SpaceX inks $920M monthly AI GPU deal with Google ahead of IPO, locking 110,000 Nvidia GPUs through 2029.
SpaceX signed a $920 million monthly compute-leasing agreement with Google, granting access to about 110,000 Nvidia GPUs through mid-2029. This deal, revealed just days before SpaceX's IPO, includes an exit clause for Google if SpaceX fails to delive...

Korean equities lead AI-driven growth with strong earnings, exports, and evolving industrial base.
Korean equities are benefiting from the AI-driven supercycle, supported by strong earnings and export growth. The country's industrial sector has shifted from traditional heavy manufacturing to a strategic base including defense, shipbuilding, and au...

Perrigo's 10.9% dividend yield at risk due to high debt and weak cash flow, potential dividend cut looms.
Perrigo is rated Hold because of its distressed balance sheet, high leverage, and unsustainable dividend coverage. The company's 10.9% dividend yield is not supported by free cash flow, creating a near-term risk of a dividend cut unless it sells more...
